Burden of disease experienced by patients following a watch-and-wait policy for locally advanced rectal cancer: A qualitative study.


Journal

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611

Informations de publication

Date de publication:
11 2021
Historique:
revised: 25 05 2021
received: 20 01 2021
accepted: 16 06 2021
pubmed: 28 7 2021
medline: 29 1 2022
entrez: 27 7 2021
Statut: ppublish

Résumé

Patient-reported outcome measures (PROMs) are increasingly being used in routine cancer care to evaluate treatment and monitor symptoms, function and other aspects of quality of life (QoL). There is no suitable PROM for rectal cancer patients following a watch-and-wait (W&W) programme. Insight into patient experiences with this programme is an essential step in the development of a PROM. The aim of this qualitative study was to provide insights into the most important functional outcomes and QoL features experienced by patients during our W&W programme. Patients with locally advanced rectal cancer who are enrolled in the W&W programme in the Netherlands were interviewed by telephone using a semistructured interview guide. All interviews were digitally audio-recorded, transcribed verbatim and coded. A thematic approach was used to analyse the data and identify themes and subthemes of importance to patients. Eighteen patients were interviewed (78% male, mean age 68 years, range 52-83 years). Physical complaints after treatment were present, most notably gastrointestinal problems, neuropathy and fatigue. Furthermore, patients were anxious about a possible recurrence, had a fear of surgery or a stoma, or were experiencing a general feeling of apprehension in daily life. Many patients had different coping mechanisms, such as acceptance, and there were few limitations in daily life. We identified important functional outcomes, such as gastrointestinal complaints, fatigue and neuropathy, in patients who were enrolled in this W&W programme. Furthermore, an emotional burden and unmet needs were reported by these patients. These findings can be used to improve clinical practice and inform the development of a PROM.

Identifiants

pubmed: 34314550
doi: 10.1111/codi.15838
pmc: PMC9291314
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2870-2878

Informations de copyright

© 2021 The Authors. Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.

Références

Eur J Cancer. 1999 Feb;35(2):238-47
pubmed: 10448266
Dis Colon Rectum. 2018 Jun;61(6):656-666
pubmed: 29664801
Lancet. 2018 Jun 23;391(10139):2537-2545
pubmed: 29976470
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Ann Surg Oncol. 2013 Jun;20(6):1816-28
pubmed: 23269466
Psychooncology. 1999 May-Jun;8(3):230-6
pubmed: 10390735
J Clin Oncol. 2015 Dec 1;33(34):4085-92
pubmed: 26527785
Gut. 1999 Jan;44(1):77-80
pubmed: 9862829
Int J Colorectal Dis. 2014 Mar;29(3):273-83
pubmed: 24150230
Int J Surg. 2014 Nov;12(11):1221-7
pubmed: 25311774
J Behav Med. 2009 Aug;32(4):371-9
pubmed: 19308716
Gastroenterol Rep (Oxf). 2016 Aug;4(3):173-85
pubmed: 27478196
Dis Colon Rectum. 2016 Apr;59(4):264-9
pubmed: 26953984
Cancer Nurs. 2020 May/Jun;43(3):E132-E158
pubmed: 32000174
Colorectal Dis. 2015 Jan;17(1):26-37
pubmed: 25156386
Cancer Manag Res. 2020 Sep 14;12:8451-8464
pubmed: 32982439
BMJ. 2013 Jan 28;346:f167
pubmed: 23358487
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
BMJ. 2002 May 18;324(7347):1183
pubmed: 12016181
Psychooncology. 2013 Jan;22(1):1-11
pubmed: 22232030
Dis Colon Rectum. 2018 Aug;61(8):911-919
pubmed: 29697477
Radiother Oncol. 2019 Mar;132:79-84
pubmed: 30825973
J Patient Rep Outcomes. 2018 Sep 15;2:42
pubmed: 30294712
Dis Colon Rectum. 2019 Jul;62(7):802-808
pubmed: 31188180
Colorectal Dis. 2019 Jul;21(7):797-804
pubmed: 30828949
Qual Life Res. 2019 Mar;28(3):567-592
pubmed: 30284183
J Clin Oncol. 2011 Dec 10;29(35):4633-40
pubmed: 22067400
Lancet Gastroenterol Hepatol. 2017 Jul;2(7):501-513
pubmed: 28479372
J Urol. 1992 Nov;148(5):1549-57; discussion 1564
pubmed: 1279218
World J Gastroenterol. 2020 Aug 7;26(29):4218-4239
pubmed: 32848330
Eur J Surg Oncol. 2020 Sep;46(9):1634-1641
pubmed: 32336626
Dis Colon Rectum. 2017 Oct;60(10):1032-1040
pubmed: 28891846
Int J Colorectal Dis. 2014 Feb;29(2):165-75
pubmed: 24136155
J Sex Marital Ther. 2000 Apr-Jun;26(2):191-208
pubmed: 10782451
Ann Surg. 2012 May;255(5):922-8
pubmed: 22504191
JAMA Surg. 2019 Jan 1;154(1):47-54
pubmed: 30304338
Urology. 1997 Jun;49(6):822-30
pubmed: 9187685
JAMA. 2019 Jul 2;322(1):25-26
pubmed: 31002337
Acad Med. 2014 Sep;89(9):1245-51
pubmed: 24979285
Cancer Nurs. 2011 Jul-Aug;34(4):302-14
pubmed: 21116179
JAMA Oncol. 2019 Apr 01;5(4):e185896
pubmed: 30629084
Colorectal Dis. 2021 Nov;23(11):2870-2878
pubmed: 34314550

Auteurs

Alexander J Pennings (AJ)

Department of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.
GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands.

Merel L Kimman (ML)

Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center+, Maastricht, The Netherlands.

Anke H C Gielen (AHC)

Department of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.
Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.

Geerard L Beets (GL)

GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands.
Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Jarno Melenhorst (J)

Department of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.
NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.

Stephanie O Breukink (SO)

Department of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.
GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands.
NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH